CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 66 enrolled
Drug / intervention
Restoration of non-carious cervical lesionsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06238999
NCT06238999N/AActive

Clinical Evaluation of a New Flowable Composite for Direct Restorative Treatment of Non-carious Cervical Lesions: A Prospective Randomized Split-mouth Study

Ivoclar Vivadent AG·interventional·Posted Feb 2, 2024·Updated Oct 23, 2025

In Brief

A clinical study evaluating Restoration of non-carious cervical lesions for Non-carious Cervical Lesions. Active but no longer recruiting, targeting 66 participants across 1 site.

Detailed Summary

The overall objective of this clinical investigation is to evaluate the clinical safety and performance of the new flowable composite TM Flow for treatment of non-carious cervical lesions. Each participant receives two different fillings (test- and control material) in two different teeth. The fillings are assessed according to selected FDI criteria at baseline (7-10 days after filling placement) and after 1, 6, 12, 24, 36 and 60 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesLiechtenstein
Collaborators--

Timeline

N/AActive
2024202520262027202820292030
First PostedFeb 2, 2024
Enrollment StartFeb 20, 2024
Primary CompletionApr 30, 2024
Study CompletionDec 31, 2029
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.4 years ago

Interventions

Restoration of non-carious cervical lesionsdevice

Non-carious cervical lesions will be treated with the experimental TM Flow or the well-established Tetric EvoFlow. The treatment workflow is very similar to other flowable composites.